Skip to main content
Watch Insiders

Institutional filer profile

RA Capital Nexus Fund L.P. Insider Trades

Latest reported as Corporate insider of Sionna Therapeutics, Inc. (SION).

Purchase filings
9
Reported companies
2
Net open-market value
$70,785,040
Latest transaction
Sep 17, 2026

Affiliated corporations

Reported company relationships

SIONLatest reported

Sionna Therapeutics, Inc.

Corporate insider

ARTVPrior filing

Artiva Biotherapeutics, Inc.

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 17, 2026Sionna Therapeutics, Inc. (SION)Corporate insiderSale3,448,811$6.33$21,835,112
Jul 31, 2026Artiva Biotherapeutics, Inc. (ARTV)Corporate insiderOpen Market Purchase45,768$9.96$455,726
Jul 24, 2026Artiva Biotherapeutics, Inc. (ARTV)Corporate insiderOpen Market Purchase41,319$9.99$412,777
Jul 23, 2026Artiva Biotherapeutics, Inc. (ARTV)Corporate insiderOpen Market Purchase264,586$9.76$2,583,312
Jul 17, 2026Artiva Biotherapeutics, Inc. (ARTV)Corporate insiderOpen Market Purchase160,354$8.93$1,432,122
Jul 13, 2026Artiva Biotherapeutics, Inc. (ARTV)Corporate insiderOpen Market Purchase21,654$8.96$194,039
Jun 26, 2026Artiva Biotherapeutics, Inc. (ARTV)Corporate insiderOpen Market Purchase32,876$8.89$292,126
Jun 16, 2026Artiva Biotherapeutics, Inc. (ARTV)Corporate insiderOpen Market Purchase531,326$8.66$4,599,902
Jun 11, 2026Artiva Biotherapeutics, Inc. (ARTV)Corporate insiderOpen Market Purchase1,027,722$7.44$7,650,157
May 11, 2026Artiva Biotherapeutics, Inc. (ARTV)Corporate insiderOpen Market Purchase6,510,416$11.52$74,999,992